報價延遲最少15分鐘:2026/10/21 16:30 EDT
盤後時段
|
||||
|
18.41 
|
|
|
常規時段 (已結束)
|
|
|
|
|
||||||||||||
|
|
|
|
|
18.41
|
|
|
| 價值評估 |
|
盈利(現時/預測)
-1.56/-1.56
|
|
企業價值
4.07B
|
| 資產負債 |
|
每股賬面淨值
4.06
|
| 現金流量 |
|
現金流量率
--
|
| 損益表 |
|
收益
15.36M
|
|
每股收益
0.12
|
|
同行比較
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
同行比較之報價最少15分鐘延遲 (夜盤時段除外)
|
業務概覽
|
|||
| Relay Therapeutics Inc is a clinical-stage precision medicine company transforming the drug discovery process and bringing life-changing therapies to patients. The Dynamo platform of the company integrates an array of leading-edge computational and experimental approaches designed to drug-protein targets that have previously been intractable or inadequately addressed. The company is advancing a pipeline of medicine candidates to address targets in precision oncology and genetic disease, including product candidates, RLY-8186, RLY-2608, RLY-4008 and others. |
